Corporate ActionApr 29, 2026, 04:54 PM
SNTI Completes Holding Company Reorganization
AI Summary
Senti Biosciences, Inc. filed a Form 10-K/A to amend its annual report, primarily to reflect a holding company reorganization completed on April 24, 2026. Under this reorganization, the former Senti Biosciences became a wholly-owned subsidiary of Senti Holdings, which is now a wholly-owned subsidiary of the Company. The amendment also updates details on directors, executive officers, corporate governance, and non-employee director compensation, including cash retainers and equity awards.
Key Highlights
- Completed holding company reorganization on April 24, 2026.
- Former Senti Biosciences became a wholly-owned subsidiary of Senti Holdings.
- Senti Holdings is a wholly-owned subsidiary of the successor registrant.
- Non-employee directors receive an annual board retainer of $35,000.
- Audit Committee Chairperson receives an additional annual retainer of $15,000.
- Initial equity award for non-employee directors is 43,900 common shares.
Price Impact
More from SNTI